خانه › کارسینوم سلول سنگفرشی سر و گردن › ایلینوی › Chicago
آزمایش‌های بالینی کارسینوم سلول سنگفرشی سر و گردن در Chicago، IL
26 مطالعه برای کارسینوم سلول سنگفرشی سر و گردن در مراکز Chicago (در شعاع حدود ۳۰ مایل) در جستجوی شرکت‌کننده هستند. یک مطالعه را باز کنید تا شرایط شرکت و نحوه تماس با تیم پژوهشی را ببینید.
متن رسمی مطالعه (انگلیسی)
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
در حال جذب شرکت‌کنندهمرحله 3
- Advocate Illinois Masonic Medical Center, Chicago
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
در حال جذب شرکت‌کنندهمرحله 2/3
- Captain James A Lovell Federal Health Care Center-VA North Chicago (Site # 133), Chicago
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- University of Chicago Hospital, Chicago
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- Exelixis Clinical Site #26, Chicago
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
در حال جذب شرکت‌کنندهمرحله 3
- University of Chicago Comprehensive Cancer Center, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
در حال جذب شرکت‌کنندهمرحله 2
- Northwestern University, Chicago
- University of Illinois, Chicago
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
در حال جذب شرکت‌کنندهمرحله 3
- Rush University Medical Center Rush University Cancer Center Chicago, Chicago
- The University of Chicago Medical Center (UCMC), Chicago
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
در حال جذب شرکت‌کنندهمرحله 1/2
- The University of Chicago Medical Center (UCMC), Chicago
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
در حال جذب شرکت‌کنندهمرحله 2
- Northwestern University, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- Northwestern University Feinberg School of Medicine, Chicago
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
در حال جذب شرکت‌کنندهمرحله 2
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
در حال جذب شرکت‌کنندهمطالعه مشاهده‌ای
- Northwestern University Feinberg School of Medicine, Chicago
A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors
در حال جذب شرکت‌کنندهمرحله 1
- University of Chicago Medical Center /ID# 276638, Chicago
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
در حال جذب شرکت‌کنندهمرحله 2/3
- Northwestern University, Chicago
- Rush MD Anderson Cancer Center, Chicago
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
در حال جذب شرکت‌کنندهمرحله 2
- Northwestern University, Chicago
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
در حال جذب شرکت‌کنندهمرحله 3
- Northwestern University, Chicago
SMP-3124LP in Adults With Advanced Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1/2
- Northwestern Medicine Cancer Center, Chicago
- The University of Chicago, Chicago
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- UChicago Medicine - River East, Chicago
- The University Of Chicago, Chicago
- University of Chicago Medical Center, Chicago
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1/2
- The University of Chicago Medical Center - Oncology, Chicago
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
در حال جذب شرکت‌کنندهمرحله 1
- University of Illinois Hospital and Health Sciences System /ID# 251750, Chicago
- University of Chicago Medical Center /ID# 276271, Chicago
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
در حال جذب شرکت‌کنندهمرحله 2
- University of Chicago Comprehensive Cancer Center, Chicago
A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers
در حال جذب شرکت‌کنندهمرحله 2/3
- The University of Chicago, Chicago
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
در حال جذب شرکت‌کنندهمرحله 3
- University of Illinois Cancer Center, Chicago
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
در حال جذب شرکت‌کنندهمرحله 1
- The University of Chicago, Chicago
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
در حال جذب شرکت‌کنندهمرحله 1
- The University of Chicago Comprehensive Cancer Center, Chicago
A Study of NX-1607 in Adults With Advanced Malignancies
در حال جذب شرکت‌کنندهمرحله 1
- University of Chicago, Chicago
آزمایش‌های کارسینوم سلول سنگفرشی سر و گردن در سایر شهرها
- Houston, TX47 مطالعه
- Los Angeles, CA42 مطالعه
- Boston, MA40 مطالعه
- Nashville, TN39 مطالعه
- New York City, NY39 مطالعه
- St. Louis, MO28 مطالعه
- Arlington, VA26 مطالعه
- Philadelphia, PA26 مطالعه
- Atlanta, GA24 مطالعه
- Pittsburgh, PA22 مطالعه
- New Haven, CT22 مطالعه
- San Antonio, TX22 مطالعه
سایر مطالعات در Chicago
- سرطان ریه غیرسلول کوچک61 مطالعه
- سرطان پستان58 مطالعه
- سرطان (همه انواع)51 مطالعه
- سرطان متاستاتیک45 مطالعه
- سرطان پروستات45 مطالعه
- چاقی41 مطالعه
- سرطان ریه41 مطالعه
- سرطان تخمدان36 مطالعه
- سکته مغزی34 مطالعه
- سرطان کولورکتال33 مطالعه
- نارسایی قلبی31 مطالعه
- اضافه وزن28 مطالعه
از ClinicalTrials.gov، داده‌ها در تاریخ 5 اکتبر 2026 دریافت شده است. هر مطالعه شرایط اختصاصی خود را دارد؛ تیم پژوهشی تصمیم می‌گیرد چه کسانی می‌توانند شرکت کنند.